Updates Related to Medicare Parts C and D related to COVID-19

A Special Enrollment Period (SEP) is available nationwide to residents of all states, tribes, territories, and the District of Columbia effective March 1, 2020.

The SEP is available for four full calendar months (through June 30, 2020).

Beneficiaries can contact 1-800-MEDICARE (1-800-633-4227) anytime, 24 hours a day, 7 days a week with any questions. TTY users should call 1-877-486-2048. They can submit their enrollment request through 1-800-MEDICARE, their agent/broker, or by contacting the Medicare health or prescription drug plan directly.

Medicare Advantage plans must provide coverage for COVID-19 diagnostic testing, including the associated cost of the visit in order to receive testing. Coverage must be provided at no cost to the beneficiary.

CMS is temporarily relaxing enforcement of rules that prevent MA plans from changing benefits mid-year in connection with the COVID outbreak, and encourages MA plans to, among other things, expand benefits, add additional benefits, and institute “more generous cost-sharing” as long as such measures are “provided uniformly to all similarly situated enrollees.”

For more information:

Questions and Answers on the Medicare Managed Care Eligibility and Enrollment webpage:


Questions and Answers on the Medicare Prescription Drug Eligibility and Enrollment webpage:

7 views0 comments

Recent Posts

See All

Medicare Open Enrollment Begins Today!

Open enrollment for Medicare health and drug plans began today! Now is a wonderful opportunity to encourage your patients who are currently enrolled in Medicare Advantage and/or prescription drug plan

COVID-19 Booster Billing Codes Issued

The National Community Pharmacists Association (NCPA) has updated its COVID-19 vaccine billing and reimbursement handout to reflect the changes in the National Council for Prescription Drug Programs'